Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides for the treatment of eye disease

Antisense oligonucleotides for the treatment of eye disease

US Patent 11479771 · Granted Oct 25, 2022

Estimated economic value: $1,584,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemically modified single-stranded rna-editing oligonucleotides2025
Single-stranded RNA-editing oligonucleotides2024
Oligonucleotide therapy for Leber congenital amaurosis2024
Nucleic acid molecules for pseudouridylation2024
Chemically modified single-stranded RNA-editing oligonucleotides2023
Single-stranded RNA-editing oligonucleotides2023
Oligonucleotide complexes for use in RNA editing2022
Oligonucleotides to treat eye disease2021
Oligonucleotides to treat eye disease2021
Oligonucleotides to treat eye disease2021
Single-stranded RNA-editing oligonucleotides2021
Chemically modified single-stranded RNA-editing oligonucleotides2021